1/1/2024 0 Comments Stem inc 2017Increased pet adoption rates as a result of the widespread practice of adopting a pet in Western countries have enabled the U.S to become such a high-revenue-generating country. North America held a value market share of 28.5% in the global animal stem cell therapy market in 2021, of which, the U.S. “Greater Penetration of Pet Care Market in the U.S.” Why are Animal Stem Cell Therapy Providers Targeting the U.S. Moreover, a variety of research and development activities will provide manufacturers with attractive opportunities to expand their business in this domain. Veterinary treatments are fostered by a range of indicators, including the growing trend of pet humanization and an increase in the number of pet adoptions.Īs a result, pet owners will drive positive demand for higher levels of veterinary care, which will increase market prospects. pet industry expenditure inflated from US$ 90.5 Bn in 2018 to US$ 123.6 Bn, as per their findings. owned 69.0 Mn dogs, 45.3 Mn cats, and 3.5 Mn horses. According to the American Pet Products Association, in 2021, it was estimated that families in the U.S.Key players have numerous opportunities to expand their businesses in emerging markets as well. Many attractive prospects for manufacturers of animal stem cell therapy products in developed countries are expected over the forecasted period. “Pet Owners Well-informed and Expect Higher Level of Veterinary Care” What Opportunities are on Offer for Animal Stem Cell Therapy Product Manufacturers? The global animal stem cell therapy market is predicted to expand at a CAGR value of 5.2% and record sales of US$ 437.3 Mn by the end of 2032. When pet owners hear how safe and beneficial these treatments are for their animals, they get inquisitive and strive to learn everything they can about animal stem cell therapies.īecause allogeneic stem cell therapy is safer and more effective for animals than autologous stem cell therapy, it is hifavoredoured across regions. Increased spending on veterinary care also helps the animal stem cell therapy market grow. The approval of stem cell-based products is governed by several standard organizations, including the Food and Drug Administration (FDA), the Australian Pesticides and Veterinary Medicines Authority, the European Medicines Agency's (EMA) Committee for Veterinary Medicinal Products (CVMP), and others because these products have a substantial impact on animal health. ![]() The global market for animal stem cell therapy expanded at a CAGR rate of 4.7% over the historically analyzed years (2012-2021).Įxpansion of the animal stem cell therapy market is directly linked to the rising prevalence of diseases in the growing population of animals. ![]() In-depth report coverage is now just a few seconds away Get FREE Report Sample Animal Stem Cell Therapy Demand Analysis (2012 to 2021) Vs.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |